• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

达格列净通过激活 AMPK 减轻心肌成纤维细胞中的钠/氢交换蛋白-1。

Dapagliflozin Attenuates Na/H Exchanger-1 in Cardiofibroblasts via AMPK Activation.

机构信息

The Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.

The Section of Cardiology, The Department of Medicine, Baylor College of Medicine, Houston, TX, 77030, USA.

出版信息

Cardiovasc Drugs Ther. 2018 Dec;32(6):553-558. doi: 10.1007/s10557-018-6837-3.

DOI:10.1007/s10557-018-6837-3
PMID:30367338
Abstract

PURPOSE

We assessed whether the SGLT-2 inhibitor dapagliflozin (Dapa) attenuates the upregulation of the cardiac Na/H exchanger (NHE-1) in vitro in mouse cardiofibroblasts stimulated with lipopolysaccharides (LPS) and whether this effect is dependent on adenosine monophosphate kinase (AMPK) activation.

METHODS

Mouse cardiofibroblasts were exposed for 16 h to Dapa (0.4 μM), AMPK activator (A769662 (10 μM)), AMPK inhibitor (compound C (CC) (10 μM)), an SGLT-1 and SGLT-2 inhibitor (phlorizin (PZ) (100 μM)), Dapa+CC, or Dapa+PZ, and then stimulated with LPS (10 ng/ml) for 3 h. NHE-1 mRNA levels were assessed by rt-PCR and total AMPK, phosphorylated-AMPK (P-AMPK), NHE-1, and heat shock protein-70 (Hsp70) protein levels in the whole cell lysate by immunoblotting. In addition, NHE-1 protein levels attached to Hsp70 were assessed by immunoprecipitation.

RESULTS

Exposure to LPS significantly reduced P-AMPK levels in the cardiofibroblasts. A769662 and Dapa equally increased P-AMPK. The effect was blocked by CC. Phlorizin had no effect on P-AMPK. LPS exposure significantly increased NHE-1 mRNA levels. Both Dapa and A769662 equally attenuated this increase. The effect of Dapa was blocked with CC. Interestingly, none of the compounds significantly affected NHE-1 and Hsp70 protein levels in the whole cell lysate. However, LPS significantly increased the concentration of NHE-1 attached to Hsp70. Both Dapa and A69662 attenuated this association and CC blocked the effect of Dapa. Again, phlorizin had no effect and did not alter the effect of Dapa.

CONCLUSIONS

Dapa increases P-AMPK in cardiofibroblasts exposed to LPS. Dapa attenuated the increase in NHE-1 mRNA and the association between NHE-1 and Hsp70. This effect was dependent on AMPK.

摘要

目的

我们评估 SGLT-2 抑制剂达格列净(Dapa)是否能减弱脂多糖(LPS)刺激的体外鼠心脏成纤维细胞中钠/氢交换蛋白(NHE-1)的上调,并评估这种作用是否依赖于单磷酸腺苷激活的蛋白激酶(AMPK)的激活。

方法

用 0.4 μM 的达格列净、AMPK 激活剂(A769662,10 μM)、AMPK 抑制剂(化合物 C,CC,10 μM)、SGLT-1 和 SGLT-2 抑制剂(根皮苷,PZ,100 μM)、达格列净+CC 或达格列净+PZ 处理鼠心脏成纤维细胞 16 小时,然后用 LPS(10 ng/ml)刺激 3 小时。通过逆转录聚合酶链反应评估 NHE-1 mRNA 水平,通过免疫印迹法评估全细胞裂解物中总 AMPK、磷酸化 AMPK(P-AMPK)、NHE-1 和热休克蛋白-70(Hsp70)的蛋白水平。此外,通过免疫沉淀法评估附着在 Hsp70 上的 NHE-1 蛋白水平。

结果

LPS 处理显著降低了心脏成纤维细胞中的 P-AMPK 水平。A769662 和达格列净同样增加了 P-AMPK。CC 阻断了这一作用。根皮苷对 P-AMPK 没有影响。LPS 暴露显著增加了 NHE-1 mRNA 水平。达格列净和 A769662 同样减弱了这种增加。CC 阻断了达格列净的作用。有趣的是,没有一种化合物显著影响全细胞裂解物中的 NHE-1 和 Hsp70 蛋白水平。然而,LPS 显著增加了与 Hsp70 结合的 NHE-1 浓度。达格列净和 A769662 减弱了这种结合,CC 阻断了达格列净的作用。根皮苷没有作用,也没有改变达格列净的作用。

结论

达格列净增加了 LPS 刺激的心脏成纤维细胞中的 P-AMPK。达格列净减弱了 NHE-1 mRNA 的增加和 NHE-1 与 Hsp70 之间的关联。这种作用依赖于 AMPK。

相似文献

1
Dapagliflozin Attenuates Na/H Exchanger-1 in Cardiofibroblasts via AMPK Activation.达格列净通过激活 AMPK 减轻心肌成纤维细胞中的钠/氢交换蛋白-1。
Cardiovasc Drugs Ther. 2018 Dec;32(6):553-558. doi: 10.1007/s10557-018-6837-3.
2
SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor.达格列净抑制SGLT-2可降低Nlrp3/ASC炎性小体的激活,并减轻2型糖尿病小鼠糖尿病性心肌病的发展。二肽基肽酶4抑制剂沙格列汀可进一步增强其作用效果。
Cardiovasc Drugs Ther. 2017 Apr;31(2):119-132. doi: 10.1007/s10557-017-6725-2.
3
Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells.坎格列净对脂多糖刺激的人冠状动脉内皮细胞中己糖激酶 II 的新型抗炎作用。
Cardiovasc Drugs Ther. 2021 Dec;35(6):1083-1094. doi: 10.1007/s10557-020-07083-w. Epub 2020 Oct 13.
4
Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: potential relevance to prevention of cardiovascular events.钠-葡萄糖共转运蛋白 2 抑制剂拮抗人髓样血管生成细胞的脂毒性和人血小板中 ADP 依赖性激活:对预防心血管事件的潜在相关性。
Cardiovasc Diabetol. 2020 Apr 7;19(1):46. doi: 10.1186/s12933-020-01016-5.
5
Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na/H exchanger, lowering of cytosolic Na and vasodilation.SGLT2 抑制剂在小鼠心肌细胞和心脏中的类效应:抑制 Na/H 交换器,降低细胞溶质 Na 并扩张血管。
Diabetologia. 2018 Mar;61(3):722-726. doi: 10.1007/s00125-017-4509-7. Epub 2017 Dec 2.
6
Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.联合 SGLT2 和 DPP4 抑制可减少 2 型糖尿病小鼠 NLRP3/ASC 炎性小体的激活并减轻糖尿病肾病的发展。
Cardiovasc Drugs Ther. 2018 Apr;32(2):135-145. doi: 10.1007/s10557-018-6778-x.
7
Dapagliflozin attenuates steatosis in livers of high-fat diet-induced mice and oleic acid-treated L02 cells via regulating AMPK/mTOR pathway.达格列净通过调节 AMPK/mTOR 通路减轻高脂饮食诱导的小鼠肝脏脂肪变性和油酸处理的 L02 细胞脂肪变性。
Eur J Pharmacol. 2021 Sep 15;907:174304. doi: 10.1016/j.ejphar.2021.174304. Epub 2021 Jul 3.
8
Dapagliflozin attenuates arrhythmic vulnerabilities by regulating connexin43 expression via the AMPK pathway in post-infarcted rat hearts.达格列净通过调节 AMPK 通路改善梗死大鼠心脏缝隙连接蛋白 43 的表达从而减轻心律失常易损性。
Biochem Pharmacol. 2021 Oct;192:114674. doi: 10.1016/j.bcp.2021.114674. Epub 2021 Jul 9.
9
Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK-mTOR Interplay.达格列净和替格瑞洛对 NLRP3 炎性小体激活和糖尿病心肌病进展的抑制作用具有相加效应:AMPK-mTOR 相互作用。
Cardiovasc Drugs Ther. 2020 Aug;34(4):443-461. doi: 10.1007/s10557-020-06978-y.
10
Effectiveness in the inhibition of dapagliflozin and canagliflozin on M-type K current and α-methylglucoside-induced current in pituitary tumor (GH) and pheochromocytoma PC12 cells.达格列净和卡格列净对脑垂体瘤 (GH) 和嗜铬细胞瘤 PC12 细胞 M 型钾电流和 α-甲基葡萄糖苷诱导电流的抑制作用。
Eur J Pharmacol. 2020 Jul 15;879:173141. doi: 10.1016/j.ejphar.2020.173141. Epub 2020 Apr 27.

引用本文的文献

1
Effects of SGLT2 inhibitors on ion channels in heart failure: focus on the endothelium.钠-葡萄糖协同转运蛋白2抑制剂对心力衰竭中离子通道的影响:聚焦于内皮细胞。
Basic Res Cardiol. 2025 May 14. doi: 10.1007/s00395-025-01115-y.
2
Sodium-Glucose Transporter-2 Inhibitors (SGLT2i) and Myocardial Ischemia: Another Compelling Reason to Consider These Agents Regardless of Diabetes.钠-葡萄糖协同转运蛋白2抑制剂(SGLT2i)与心肌缺血:无论是否患有糖尿病,都有另一个令人信服的理由考虑使用这些药物。
Int J Mol Sci. 2025 Feb 27;26(5):2103. doi: 10.3390/ijms26052103.
3
Danuglipron Ameliorates Pressure Overload-Induced Cardiac Remodelling Through the AMPK Pathway.
达努格列净通过AMPK途径改善压力超负荷诱导的心脏重塑。
J Cell Mol Med. 2025 Mar;29(5):e70488. doi: 10.1111/jcmm.70488.
4
Molecular Pathways in Diabetic Cardiomyopathy and the Role of Anti-hyperglycemic Drugs Beyond Their Glucose Lowering Effect.糖尿病心肌病的分子途径及降糖药物降糖以外的作用
J Lipid Atheroscler. 2025 Jan;14(1):54-76. doi: 10.12997/jla.2025.14.1.54. Epub 2024 Nov 28.
5
Effects of Empagliflozin and Dapagliflozin in alleviating cardiac fibrosis through SIRT6-mediated oxidative stress reduction.恩格列净和达格列净通过降低SIRT6介导的氧化应激来减轻心脏纤维化的作用。
Sci Rep. 2024 Dec 28;14(1):30764. doi: 10.1038/s41598-024-80829-w.
6
SGLT2 inhibitors for alleviating heart failure through non-hypoglycemic mechanisms.通过非降糖机制缓解心力衰竭的钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂
Front Cardiovasc Med. 2024 Dec 9;11:1494882. doi: 10.3389/fcvm.2024.1494882. eCollection 2024.
7
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Guardians against Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Heart Diseases.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂:心脏病中线粒体功能障碍和内质网应激的守护者
ACS Pharmacol Transl Sci. 2024 Oct 16;7(11):3279-3298. doi: 10.1021/acsptsci.4c00240. eCollection 2024 Nov 8.
8
CTRP6-mediated cardiac protection in heart failure via the AMPK/SIRT1/PGC-1α signalling pathway.CTRP6 通过 AMPK/SIRT1/PGC-1α 信号通路介导心力衰竭中的心脏保护作用。
Exp Physiol. 2024 Dec;109(12):2031-2045. doi: 10.1113/EP092036. Epub 2024 Sep 26.
9
SGLT2 inhibitors: how do they affect the cardiac cells.钠-葡萄糖协同转运蛋白2抑制剂:它们如何影响心脏细胞?
Mol Cell Biochem. 2025 Mar;480(3):1359-1379. doi: 10.1007/s11010-024-05084-z. Epub 2024 Aug 19.
10
The Remaining Conundrum of the Role of the Na/H Exchanger Isoform 1 (NHE1) in Cardiac Physiology and Pathology: Can It Be Rectified?钠/氢交换体1型(NHE1)在心脏生理和病理中的作用所遗留的难题:能否得到解决?
Rev Cardiovasc Med. 2022 Aug 15;23(8):284. doi: 10.31083/j.rcm2308284. eCollection 2022 Aug.